Patents by Inventor Ganesh Vasudevan

Ganesh Vasudevan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210377039
    Abstract: A system for protecting personal information uses a challenge and an encrypted copy of the challenge in the form of a message authentication code (MAC) to provide authentication among multiple parties. The challenge is received by a first party from a second party. The challenge is encrypted by the first party to form the MAC and then both the challenge and the MAC are returned to the second party. The second party authenticates the first party by confirming the challenge. The second party sends the MAC and challenge to the third party. The third party decrypts the MAC using a key shared with the first party. When the decrypted MAC matches the challenge, the first party is authenticated to the third party. The process is applicable to transaction processing to limit compromise of payment instrument details.
    Type: Application
    Filed: September 12, 2018
    Publication date: December 2, 2021
    Inventors: Hari Krishna Annam, Selva Ganesh Vasudevan
  • Publication number: 20150011419
    Abstract: The present invention provides systems and methods for characterizing biological markers in the urine of systemic lupus erythematosus (SLE) subjects. In particular, the present invention relates to the detection of cytokines and chemokines in urine of SLE subjects for determining nephritic disease states and kidney damage in SLE subjects and the efficacy of agents and interventions used to treat lupus nephritis.
    Type: Application
    Filed: September 25, 2014
    Publication date: January 8, 2015
    Inventors: Ganesh Vasudevan, Huaizhong Hu, Stuart Knechtle
  • Publication number: 20110236912
    Abstract: The present invention provides systems and methods for characterizing biological markers in the urine of systemic lupus erythematosus (SLE) subjects. In particular, the present invention relates to the detection of cytokines and chemokines in urine of SLE subjects for determining nephritic disease states and kidney damage in SLE subjects and the efficacy of agents and interventions used to treat lupus nephritis.
    Type: Application
    Filed: November 3, 2009
    Publication date: September 29, 2011
    Applicant: Renovar, Inc.
    Inventors: Ganesh Vasudevan, Huaizhong Hu, Stuart Knechtle